+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Nicotinamide Mononucleotide (NMN) Global Market

Nicotinamide Mononucleotide (NMN) Global Market

Global Nicotinamide Mononucleotide (NMN) Market Industry Research Report 2026

Explore detailed insights, trends, growth drivers, key players, and forecasts for the Global Nicotinamide Mononucleotide (NMN) Market Industry Research Report 2026 market worldwide.

Pages: 220

Format: PDF

Date: 01-2026

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Nicotinamide Mononucleotide (NMN) Market Report (2026–2036)

Market Overview

Chem Reports projects that the Nicotinamide Mononucleotide (NMN) Market, valued at USD xxxx units in 2025, is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% globally.

The Global NMN Market Report 2025 provides an extensive industry analysis of development drivers, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2026–2036. This research integrates both primary and secondary data sources, examining government policies, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic has spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the NMN market in 2020, disrupting supply chains, altering demand patterns, and reshaping investment priorities across dietary supplements, pharmaceuticals, and food & beverage sectors.

Market Segmentation

By Type

  • Pharm Grade
  • Food Grade
  • Others

By Application

  • Dietary Supplements
  • Pharmaceutical
  • Food & Beverages
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Nicotinamide Mononucleotide (NMN) market include:

  • Shenzhen Ejion Biotechnology
  • Hangzhou Zhiju Biotechnology Co. Ltd.
  • Suzhou Pilot Biological Technology Co. Ltd.
  • Zhejiang Jiahua Chemical Co. Ltd.
  • Hangzhou Weitai Biological Pharmaceutical Co. Ltd.
  • Suzhou Mailun Biotechnology Co. Ltd.

Global Nicotinamide Mononucleotide (NMN) Market Intelligence Brief (2026–2036)

Short Description / Definition

Nicotinamide Mononucleotide (NMN) is a bioactive nucleotide and precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular energy metabolism and longevity research. NMN is increasingly used in dietary supplements, pharmaceuticals, and functional foods due to its potential anti-aging and metabolic health benefits.

Regional Analysis

  • North America: Strong demand in dietary supplements and pharmaceuticals. The U.S. leads adoption, supported by advanced nutraceutical R&D and regulatory oversight.
  • Europe: Growth driven by functional foods and nutraceutical innovation. Germany, France, and the U.K. are key hubs, with emphasis on sustainability and consumer health trends.
  • Asia-Pacific: Fastest-growing region, led by China, Japan, and India. Expansion fueled by consumer interest in anti-aging supplements, government healthcare initiatives, and strong nutraceutical manufacturing bases.
  • South America: Moderate growth, with Brazil showing demand in dietary supplements and functional foods.
  • Middle East & Africa: Emerging adoption in health and wellness products, though market penetration remains limited compared to other regions.

Porter’s Five Forces

  1. Competitive Rivalry: High; global players (Suzhou Pilot, Hangzhou Zhiju, Shenzhen Ejion) compete with regional biotech firms.
  2. Threat of New Entrants: Moderate; entry barriers include regulatory approvals, clinical validation, and capital-intensive production.
  3. Bargaining Power of Suppliers: Moderate; raw material suppliers hold leverage due to limited sources of high-purity NMN.
  4. Bargaining Power of Buyers: High; nutraceutical and pharmaceutical companies demand cost-effective, compliant NMN.
  5. Threat of Substitutes: Moderate; alternatives like nicotinamide riboside (NR) exist but NMN remains relevant due to strong clinical interest.

SWOT Analysis

Strengths

  • Established role in NAD+ biosynthesis.
  • Wide applicability in supplements, pharmaceuticals, and functional foods.
  • Strong consumer demand for anti-aging and metabolic health products.

Weaknesses

  • High production and compliance costs.
  • Regulatory uncertainty in nutraceutical markets.

Opportunities

  • Rising global interest in longevity and wellness.
  • Growth in Asia-Pacific nutraceutical manufacturing.
  • Development of pharmaceutical-grade NMN for clinical applications.

Threats

  • Raw material price volatility.
  • Stringent regulatory hurdles in supplements and pharmaceuticals.
  • Competition from alternative NAD+ precursors.

Trend Analysis

  • Increasing use in dietary supplements for anti-aging and metabolic health.
  • Rising demand in pharmaceuticals for clinical trials targeting age-related diseases.
  • Growth in functional foods and beverages incorporating NMN.
  • Expansion of bio-based production technologies for cost efficiency and sustainability.

Drivers & Challenges

Drivers

  • Expanding nutraceutical and wellness industries.
  • Rising consumer awareness of longevity science.
  • Technological advancements in NMN synthesis and purification.

Challenges

  • High R&D and compliance costs.
  • Regulatory restrictions on supplement claims.
  • Supply chain disruptions for raw materials.

Value Chain Analysis

  • Raw Materials: Nicotinamide precursors, fermentation inputs.
  • Manufacturing: NMN synthesis, purification, GMP compliance.
  • Distribution: Global distributors, nutraceutical partnerships.
  • End-Use Industries: Dietary supplements, pharmaceuticals, functional foods.
  • Regulatory Bodies: FDA, EFSA, CFDA shaping compliance requirements.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in R&D for pharmaceutical-grade NMN and bio-based production methods.
  • Investors: Focus on Asia-Pacific nutraceutical markets where growth potential is strongest.
  • Regulators: Support harmonized global standards for supplement safety and efficacy.
  • Pharma Companies: Collaborate with NMN suppliers to develop clinical-grade formulations.
  • Distributors: Expand presence in emerging wellness markets with campaigns highlighting anti-aging benefits.

Explore more reports here-

https://chemreports.com/reports

 

1. Market Overview of Nicotinamide Mononucleotide (NMN)
    1.1 Nicotinamide Mononucleotide (NMN) Market Overview
        1.1.1 Nicotinamide Mononucleotide (NMN) Product Scope
        1.1.2 Market Status and Outlook
    1.2 Nicotinamide Mononucleotide (NMN) Market Size by Regions:
    1.3 Nicotinamide Mononucleotide (NMN) Historic Market Size by Regions
    1.4 Nicotinamide Mononucleotide (NMN) Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2025 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Nicotinamide Mononucleotide (NMN) Sales Market by Type
    2.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Size by Type
    2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Market Size by Type
    2.3 Pharm Grade
    2.4 Food Grade
    2.5 Others
3. Covid-19 Impact Nicotinamide Mononucleotide (NMN) Sales Market by Application
    3.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Size by Application
    3.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Market Size by Application
    3.3 Dietary Supplements
    3.4 Pharmaceutical
    3.5 Food & Beverages
    3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Nicotinamide Mononucleotide (NMN) Production Capacity Market Share by Manufacturers
    4.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers
    4.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers
5. Company Profiles and Key Figures in Nicotinamide Mononucleotide (NMN) Business
    5.1 Shenzhen Ejion Biotechnologgy
        5.1.1 Shenzhen Ejion Biotechnologgy Company Profile
        5.1.2 Shenzhen Ejion Biotechnologgy Nicotinamide Mononucleotide (NMN) Product Specification
        5.1.3 Shenzhen Ejion Biotechnologgy Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
    5.2 Hangzhou Zhiju Biotechnology Co. Ltd.
        5.2.1 Hangzhou Zhiju Biotechnology Co. Ltd. Company Profile
        5.2.2 Hangzhou Zhiju Biotechnology Co. Ltd. Nicotinamide Mononucleotide (NMN) Product Specification
        5.2.3 Hangzhou Zhiju Biotechnology Co. Ltd. Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
    5.3 Suzhou Pilot Biological Technology Co. Ltd.
        5.3.1 Suzhou Pilot Biological Technology Co. Ltd. Company Profile
        5.3.2 Suzhou Pilot Biological Technology Co. Ltd. Nicotinamide Mononucleotide (NMN) Product Specification
        5.3.3 Suzhou Pilot Biological Technology Co. Ltd. Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
    5.4 Zhejiang Jiahua Chemical Co. Ltd.
        5.4.1 Zhejiang Jiahua Chemical Co. Ltd. Company Profile
        5.4.2 Zhejiang Jiahua Chemical Co. Ltd. Nicotinamide Mononucleotide (NMN) Product Specification
        5.4.3 Zhejiang Jiahua Chemical Co. Ltd. Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
    5.5 Hangzhou Weitai Biological Pharmaceutical Co. Ltd.
        5.5.1 Hangzhou Weitai Biological Pharmaceutical Co. Ltd. Company Profile
        5.5.2 Hangzhou Weitai Biological Pharmaceutical Co. Ltd. Nicotinamide Mononucleotide (NMN) Product Specification
        5.5.3 Hangzhou Weitai Biological Pharmaceutical Co. Ltd. Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
    5.6 Suzhou Mailun Biotechnology Co. Ltd.
        5.6.1 Suzhou Mailun Biotechnology Co. Ltd. Company Profile
        5.6.2 Suzhou Mailun Biotechnology Co. Ltd. Nicotinamide Mononucleotide (NMN) Product Specification
        5.6.3 Suzhou Mailun Biotechnology Co. Ltd. Nicotinamide Mononucleotide (NMN) Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Nicotinamide Mononucleotide (NMN) Market Size
    6.2 North America Nicotinamide Mononucleotide (NMN) Key Players in North America
    6.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Type
    6.4 North America Nicotinamide Mononucleotide (NMN) Market Size by Application
7. East Asia
    7.1 East Asia Nicotinamide Mononucleotide (NMN) Market Size
    7.2 East Asia Nicotinamide Mononucleotide (NMN) Key Players in North America
    7.3 East Asia Nicotinamide Mononucleotide (NMN) Market Size by Type
    7.4 East Asia Nicotinamide Mononucleotide (NMN) Market Size by Application
8. Europe
    8.1 Europe Nicotinamide Mononucleotide (NMN) Market Size
    8.2 Europe Nicotinamide Mononucleotide (NMN) Key Players in North America
    8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Type
    8.4 Europe Nicotinamide Mononucleotide (NMN) Market Size by Application
9. South Asia
    9.1 South Asia Nicotinamide Mononucleotide (NMN) Market Size
    9.2 South Asia Nicotinamide Mononucleotide (NMN) Key Players in North America
    9.3 South Asia Nicotinamide Mononucleotide (NMN) Market Size by Type
    9.4 South Asia Nicotinamide Mononucleotide (NMN) Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Market Size
    10.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Key Players in North America
    10.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Market Size by Type
    10.4 Southeast Asia Nicotinamide Mononucleotide (NMN) Market Size by Application
11. Middle East
    11.1 Middle East Nicotinamide Mononucleotide (NMN) Market Size
    11.2 Middle East Nicotinamide Mononucleotide (NMN) Key Players in North America
    11.3 Middle East Nicotinamide Mononucleotide (NMN) Market Size by Type
    11.4 Middle East Nicotinamide Mononucleotide (NMN) Market Size by Application
12. Africa
    12.1 Africa Nicotinamide Mononucleotide (NMN) Market Size
    12.2 Africa Nicotinamide Mononucleotide (NMN) Key Players in North America
    12.3 Africa Nicotinamide Mononucleotide (NMN) Market Size by Type
    12.4 Africa Nicotinamide Mononucleotide (NMN) Market Size by Application
13. Oceania
    13.1 Oceania Nicotinamide Mononucleotide (NMN) Market Size
    13.2 Oceania Nicotinamide Mononucleotide (NMN) Key Players in North America
    13.3 Oceania Nicotinamide Mononucleotide (NMN) Market Size by Type
    13.4 Oceania Nicotinamide Mononucleotide (NMN) Market Size by Application
14. South America
    14.1 South America Nicotinamide Mononucleotide (NMN) Market Size
    14.2 South America Nicotinamide Mononucleotide (NMN) Key Players in North America
    14.3 South America Nicotinamide Mononucleotide (NMN) Market Size by Type
    14.4 South America Nicotinamide Mononucleotide (NMN) Market Size by Application
15. Rest of the World
    15.1 Rest of the World Nicotinamide Mononucleotide (NMN) Market Size
    15.2 Rest of the World Nicotinamide Mononucleotide (NMN) Key Players in North America
    15.3 Rest of the World Nicotinamide Mononucleotide (NMN) Market Size by Type
    15.4 Rest of the World Nicotinamide Mononucleotide (NMN) Market Size by Application
16 Nicotinamide Mononucleotide (NMN) Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • Pharm Grade
  • Food Grade
  • Others

By Application

  • Dietary Supplements
  • Pharmaceutical
  • Food & Beverages
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Nicotinamide Mononucleotide (NMN) market include:

  • Shenzhen Ejion Biotechnology
  • Hangzhou Zhiju Biotechnology Co. Ltd.
  • Suzhou Pilot Biological Technology Co. Ltd.
  • Zhejiang Jiahua Chemical Co. Ltd.
  • Hangzhou Weitai Biological Pharmaceutical Co. Ltd.
  • Suzhou Mailun Biotechnology Co. Ltd.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.